Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Capital Expenditures (2016 - 2026)

Angiodynamics' Capital Expenditures history spans 17 years, with the latest figure at $492000.0 for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 59.34% year-over-year to $492000.0; the TTM value through Feb 2026 reached $3.3 million, up 11.08%, while the annual FY2025 figure was $4.5 million, 77.28% up from the prior year.
  • Capital Expenditures reached $492000.0 in Q1 2026 per ANGO's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.2 million in Q3 2022 to a low of -$3.9 million in Q1 2022.
  • Average Capital Expenditures over 5 years is $612529.4, with a median of $1.2 million recorded in 2024.
  • Peak YoY movement for Capital Expenditures: plummeted 206.83% in 2023, then surged 206.88% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $1.2 million in 2022, then rose by 1.98% to $1.2 million in 2023, then dropped by 6.05% to $1.2 million in 2024, then increased by 10.65% to $1.3 million in 2025, then plummeted by 61.8% to $492000.0 in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Capital Expenditures are $492000.0 (Q1 2026), $1.3 million (Q4 2025), and $731000.0 (Q3 2025).